Recent progress in LyP-1-based strategies for targeted imaging and therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress in LyP-1-based strategies for targeted imaging and therapy
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 26, Issue 1, Pages 363-375
Publisher
Informa UK Limited
Online
2019-03-24
DOI
10.1080/10717544.2019.1587047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor target amplification: Implications for nano drug delivery systems
- (2018) Khaled Seidi et al. JOURNAL OF CONTROLLED RELEASE
- LyP-1-conjugated Fe3O4 nanoparticles suppress tumor growth by magnetic induction hyperthermia
- (2017) Peishan Teo et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Molecular dynamics, thermodynamic, and mutational binding studies for tumor-specific LyP-1 in complex with p32
- (2017) Selin Seda Timur et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma
- (2017) Venkata Yenugonda et al. Journal of Translational Medicine
- LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer
- (2017) Abedelnasser Abulrob et al. MOLECULAR IMAGING AND BIOLOGY
- Structure Reconstruction of LyP-1: Lc(LyP-1) Coupling by Amide Bond Inspires the Brain Metastatic Tumor Targeted Drug Delivery
- (2017) Xiaoyu Zhang et al. MOLECULAR PHARMACEUTICS
- Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release
- (2017) Jeffrey D. Bjorge et al. PLoS One
- Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles
- (2016) WenTing Li et al. BIOMATERIALS
- Therapeutic hyperthermia: The old, the new, and the upcoming
- (2016) Matthew Mallory et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque
- (2016) Zhi-Gang She et al. JOURNAL OF CONTROLLED RELEASE
- Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo
- (2016) Chia-Wei Su et al. MACROMOLECULAR BIOSCIENCE
- Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer
- (2016) Selin Seda Timur et al. PHARMACEUTICAL RESEARCH
- Advances in phage display technology for drug discovery
- (2015) Kobra Omidfar et al. Expert Opinion on Drug Discovery
- Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents
- (2015) Giulio Casi et al. JOURNAL OF MEDICINAL CHEMISTRY
- The lymph node pre-metastatic niche
- (2015) Jonathan P. Sleeman JOURNAL OF MOLECULAR MEDICINE-JMM
- Atherosclerosis – A matter of unresolved inflammation
- (2015) Joana Viola et al. SEMINARS IN IMMUNOLOGY
- 64Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic Plaque
- (2014) Jai Woong Seo et al. BIOCONJUGATE CHEMISTRY
- Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
- (2014) Sophie Laurent et al. Expert Opinion on Drug Delivery
- Local tumour hyperthermia as immunotherapy for metastatic cancer
- (2014) Seiko Toraya-Brown et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Paclitaxel Formulations: Challenges and Novel Delivery Options
- (2014) Chetan Nehate et al. Current Drug Delivery
- Techniques for physicochemical characterization of nanomaterials
- (2013) Ping-Chang Lin et al. BIOTECHNOLOGY ADVANCES
- Quantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality
- (2013) Dale L. Bailey et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide
- (2013) Chong Li et al. International Journal of Nanomedicine
- Design, characterization andin vitroevaluation of SMEDDS containing an anticancer peptide, linear LyP-1
- (2013) R. Neslihan Gürsoy et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- A Novel Microfluidic Chip for Assessing Dynamic Adhesion Behavior of Cell-Targeting Microbubbles
- (2013) Fei Yan et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Current status and prospects for microbubbles in ultrasound theranostics
- (2013) K. Heath Martin et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery
- (2012) Yin Ren et al. ACS Nano
- Engineering Folate–Drug Conjugates to Target Cancer: From Chemistry to Clinic
- (2012) Iontcho R. Vlahov et al. BIOCONJUGATE CHEMISTRY
- X-ray-Computed Tomography Contrast Agents
- (2012) Hrvoje Lusic et al. CHEMICAL REVIEWS
- Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers
- (2012) Wahajuddin et al. International Journal of Nanomedicine
- Development of artemisinin compounds for cancer treatment
- (2012) Henry C. Lai et al. INVESTIGATIONAL NEW DRUGS
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
- (2012) Si Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics
- (2012) F. Kiessling et al. JOURNAL OF NUCLEAR MEDICINE
- LyP-1 Modification To Enhance Delivery of Artemisinin or Fluorescent Probe Loaded Polymeric Micelles to Highly Metastatic Tumor and Its Lymphatics
- (2012) Zhaohui Wang et al. MOLECULAR PHARMACEUTICS
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
- (2012) Y. Ren et al. Science Translational Medicine
- Applications and Potential Toxicity of Magnetic Iron Oxide Nanoparticles
- (2012) Gang Liu et al. Small
- Protein Cage Nanoparticles Bearing the LyP-1 Peptide for Enhanced Imaging of Macrophage-Rich Vascular Lesions
- (2011) Masaki Uchida et al. ACS Nano
- Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide
- (2011) Fan Zhang et al. AMINO ACIDS
- X-Ray Computed Tomography Imaging of Breast Cancer by using Targeted Peptide-Labeled Bismuth Sulfide Nanoparticles
- (2011) Joseph M. Kinsella et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature
- (2011) Thomas P. Herringson et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor
- (2011) Zhiqiang Yan et al. JOURNAL OF CONTROLLED RELEASE
- Microfluidic-assisted formation of multifunctional monodisperse microbubbles for diagnostics and therapeutics
- (2011) Chunxiang Jiang et al. Micro & Nano Letters
- LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics
- (2011) Zhiqiang Yan et al. NANOTECHNOLOGY
- Transtumoral targeting enabled by a novel neuropilin-binding peptide
- (2011) L Roth et al. ONCOGENE
- Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice
- (2011) J. Hamzah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic Ultrasonic Microbubbles Carrying Paclitaxel and LyP-1 Peptide: Preparation, Characterization and Application to Ultrasound-Assisted Chemotherapy in Breast Cancer Cells
- (2011) Fei Yan et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation
- (2010) V. Fogal et al. MOLECULAR AND CELLULAR BIOLOGY
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
- (2010) K. N. Sugahara et al. SCIENCE
- Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
- (2009) Francesca Greco et al. ADVANCED DRUG DELIVERY REVIEWS
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
- (2009) Kazuki N. Sugahara et al. CANCER CELL
- Macrophages: Promising Targets for the Treatment of Atherosclerosis
- (2009) Heather Wilson et al. Current Vascular Pharmacology
- LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors
- (2009) Guopei Luo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cooperative nanomaterial system to sensitize, target, and treat tumors
- (2009) J.-H. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
- (2009) T. Teesalu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptide Targeting of Tumor Lymph Vessels
- (2008) Pirjo Laakkonen et al. Annals of the New York Academy of Sciences
- In VivoTumor Cell Targeting with “Click” Nanoparticles
- (2008) Geoffrey von Maltzahn et al. BIOCONJUGATE CHEMISTRY
- Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma
- (2008) V. Fogal et al. CANCER RESEARCH
- Tumor targeting of baculovirus displaying a lymphatic homing peptide
- (2008) Anna R. Mäkelä et al. JOURNAL OF GENE MEDICINE
- Targeting of albumin-embedded paclitaxel nanoparticles to tumors
- (2008) Priya Prakash Karmali et al. Nanomedicine-Nanotechnology Biology and Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started